Biliary tract cancer (BTC), a rare malignancy that grows within the bile ducts and gallbladder, grows very aggressively. The fast progression associated with BTC makes it challenging to treat and ...

Bile duct cancer can often be treated more effectively when detected early. However, its initial symptoms are often mild and can resemble common digestive or liver problems, leading to delayed ...

The Food and Drug Administration (FDA) has approved ivosidenib (Tibsovo) for the treatment of adults with previously treated locally advanced or metastatic IDH1-mutated cholangiocarcinoma (CCA), a ...

Multimodal thermal therapy to promote the expansion of tumor-reactive–like CX3CR1+GPR56+ T cells in hepatocellular carcinoma patients. Safety and efficacy of HAIC or lenvatinib combined with ...